Deerfield Management Company, L.P. 13F holdings, Q3 2024
Holdings as of September 30, 2024 · filings on SEC EDGAR · latest filing →
Deerfield Management Company, L.P. disclosed 443 US equity positions worth $6.7bn in its Q3 2024 13F filing. The largest position was NUVALENT INC at 30.6% of the reported book, followed by VTRS and CNC.
What did Deerfield Management Company, L.P. own in Q3 2024? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | NUVALENT INC | 30.6% | $2.0bn | 19,991,024 | – | ||
| 2 | VTRS VIATRIS INC | Healthcare | 4.2% | $278.6m | 23,993,023 | – | |
| 3 | CNC CENTENE CORP DEL | Healthcare | 3.0% | $199.7m | 2,652,189 | – | |
| 4 | MERUS N V | 2.5% | $170.3m | 3,408,539 | – | ||
| 5 | OSCR OSCAR HEALTH INC | Healthcare | 2.5% | $166.5m | 7,851,675 | – | |
| 6 | INTEGRA LIFESCIENCES HLDGS C | 2.5% | $165.8m | 174,364,000 | – | ||
| 7 | SPRY ARS PHARMACEUTICALS INC | Healthcare | 2.4% | $160.6m | 11,077,927 | – | |
| 8 | NBIX NEUROCRINE BIOSCIENCES INC | Healthcare | 2.3% | $151.7m | 1,316,590 | – | |
| 9 | LRMR LARIMAR THERAPEUTICS INC | Healthcare | 2.1% | $139.1m | 21,231,974 | – | |
| 10 | WAY WAYSTAR HLDG CORP | Healthcare | 2.1% | $138.1m | 4,952,004 | – | |
| 11 | RVMD REVOLUTION MEDICINES INC | Healthcare | 2.0% | $132.1m | 2,912,692 | – | |
| 12 | ALHC ALIGNMENT HEALTHCARE INC | Healthcare | 1.9% | $128.3m | 10,854,985 | – | |
| 13 | CATALYST PHARMACEUTICALS INC | 1.9% | $123.8m | 6,229,634 | – | ||
| 14 | ACCOLADE INC | 1.8% | $122.0m | 132,598,000 | – | ||
| 15 | ALNY ALNYLAM PHARMACEUTICALS INC | 1.7% | $117.1m | 100,000,000 | – | ||
| 16 | AHCO ADAPTHEALTH CORP | Healthcare | 1.6% | $109.1m | 9,711,410 | – | |
| 17 | BKD BROOKDALE SR LIVING INC | Healthcare | 1.6% | $106.0m | 15,612,264 | – | |
| 18 | KURA KURA ONCOLOGY INC | Healthcare | 1.6% | $105.7m | 5,411,571 | – | |
| 19 | ALPHATEC HLDGS INC | 1.6% | $105.7m | 117,500,000 | – | ||
| 20 | MIRM MIRUM PHARMACEUTICALS INC | 1.5% | $103.0m | 70,000,000 | – | ||
| 21 | IDYA IDEAYA BIOSCIENCES INC | Healthcare | 1.2% | $82.2m | 2,594,000 | – | |
| 22 | ACH OWENS & MINOR INC NEW | Healthcare | 1.2% | $77.1m | 4,911,979 | – | |
| 23 | BAX BAXTER INTL INC | Healthcare | 1.1% | $73.0m | 1,923,100 | – | |
| 24 | BCRX BIOCRYST PHARMACEUTICALS INC | Healthcare | 0.9% | $61.8m | 8,135,804 | – | |
| 25 | SGRY SURGERY PARTNERS INC | Healthcare | 0.9% | $57.4m | 1,780,287 | – | |
| 26 | CVS CVS HEALTH CORP | Healthcare | 0.8% | $55.0m | 874,800 | – | |
| 27 | CGEM CULLINAN THERAPEUTICS INC | Healthcare | 0.8% | $54.9m | 3,280,000 | – | |
| 28 | BIO BIO RAD LABS INC | Healthcare | 0.8% | $50.7m | 151,575 | – | |
| 29 | IRON DISC MEDICINE INC | Healthcare | 0.8% | $50.3m | 1,023,265 | – | |
| 30 | INDIVIOR PLC | 0.7% | $49.7m | 5,092,642 | – | ||
| 31 | EWTX EDGEWISE THERAPEUTICS INC | 0.7% | $47.5m | 1,781,006 | – | ||
| 32 | BCAX BICARA THERAPEUTICS INC | 0.7% | $45.7m | 1,795,174 | – | ||
| 33 | CNMD CONMED CORP | Healthcare | 0.7% | $44.2m | 614,890 | – | |
| 34 | LKFT GALAPAGOS NV | Healthcare | 0.6% | $40.6m | 1,411,000 | – | |
| 35 | COGT COGENT BIOSCIENCES INC | Healthcare | 0.6% | $40.4m | 3,744,263 | – | |
| 36 | ALNY ALNYLAM PHARMACEUTICALS INC | Healthcare | 0.6% | $39.9m | 145,000 | – | |
| 37 | ENHABIT INC | 0.6% | $39.5m | 4,997,746 | – | ||
| 38 | LANTHEUS HLDGS INC | 0.6% | $39.3m | 25,255,000 | – | ||
| 39 | EMBC EMBECTA CORP | Healthcare | 0.6% | $38.5m | 2,730,343 | – | |
| 40 | PHVS PHARVARIS N V | 0.6% | $37.6m | 2,031,700 | – | ||
| 41 | CATX PERSPECTIVE THERAPEUTICS INC | 0.6% | $37.6m | 2,817,763 | – | ||
| 42 | GPCR STRUCTURE THERAPEUTICS INC | Healthcare | 0.6% | $37.1m | 844,407 | – | |
| 43 | DAWNGBX DAY ONE BIOPHARMACEUTICALS I | 0.5% | $36.5m | 2,617,713 | – | ||
| 44 | TXG 10X GENOMICS INC | Healthcare | 0.5% | $34.1m | 1,508,943 | – | |
| 45 | CGON CG ONCOLOGY INC | Healthcare | 0.5% | $32.1m | 850,695 | – | |
| 46 | DCGO DOCGO INC | 0.4% | $30.1m | 9,066,138 | – | ||
| 47 | FHTX FOGHORN THERAPEUTICS INC | Healthcare | 0.4% | $28.2m | 3,027,886 | – | |
| 48 | MREO MEREO BIOPHARMA GROUP PLC | Healthcare | 0.4% | $27.6m | 6,710,429 | – | |
| 49 | SVRA SAVARA INC | Healthcare | 0.4% | $27.4m | 6,465,777 | – | |
| 50 | INMD INMODE LTD | Healthcare | 0.4% | $26.8m | 1,578,708 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.